$24.7+ Billion Recombinant Vaccines Market - 2031 North America currently leads the market
PORTLAND, OR, UNITED STATES, December 2, 2024 /EINPresswire.com/ -- The global recombinant vaccines market is experiencing significant growth, with a valuation of $8.1 billion in 2021 projected to reach $24.7 billion by 2031, reflecting a robust …